Why Trace Opioid Detection Is Different From a Verified Adulterated Dose

Short answer: Detecting an unexpected opioid at trace level does not, by itself, establish that a product contained an active adulterating dose. In a British Columbia drug-checking study, 189 of 8,889 samples not expected to include fentanyl had an unexpected opioid, and 61.4% of those detections were at trace concentration. The authors considered contamination, misrepresented samples and adulteration as different possible explanations.

What was actually submitted?

Wallace and colleagues examined drug-checking submissions from 2021–2023. The 8,889-sample subset was defined by what the submitter expected the sample to contain. That expectation is a description, not a chemical test. The laboratory’s finding refers to the submitted material, not a person’s blood or an observed dose.

Why distinguish trace from above-trace findings?

Most unexpected-opioid detections in the relevant subset were trace-level. The authors report that the combination of the expected drug with an unexpected opioid above trace was the least common scenario, below 1%. This distinction helps prevent the statement “opioid detected” from becoming an unsupported claim that a particular person received a pharmacologically important dose.

A trace may have several origins, and the study does not identify a single origin for every positive sample. Likewise, a sample that lacks its expected drug raises a different interpretation problem from a sample that contains both the expected drug and an unexpected opioid.

What would an individual case require?

Identify the tested product or biological specimen, analytical method, concentrations, limits and chain of custody. Separate detected compounds from reported product labels, exposure, dose and clinical effect. The British Columbia study informs how mixed sample patterns can be read; it cannot establish what was in an untested packet or why one person experienced an overdose.

Scientific source

Wallace B, Shkolnikov I, Kielty C, et al. Is fentanyl in everything? Examining the unexpected occurrence of illicit opioids in British Columbia’s drug supply. Harm Reduction Journal. 2025;22:28. doi:10.1186/s12954-025-01189-w. Based on the supplied full paper.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Why Trace Opioid Detection Is Different From a Verified Adulterated Dose

Short answer: Detecting an unexpected opioid at trace level does not, by itself, establish that a product contained an active adulterating dose. In a British Columbia drug-checking study, 189 of 8,889 samples not expected to include fentanyl had an unexpected opioid, and 61.4% of those detections were at trace concentration….

Spread the love

Read Article: Why Trace Opioid Detection Is Different From a Verified Adulterated Dose

Were Nitazenes Present in Most Ontario Opioid Deaths? Read the 79-of-8,719 Denominator

Short answer: No. In coroner data analyzed for a Canadian study, nitazenes were present in 79 of 8,719 Ontario opioid deaths (0.91%) from January 2019 through December 2022. The Toronto subset was 33 of 1,803 opioid deaths (1.83%). These are presence counts in specified death records, not evidence that nitazenes…

Spread the love

Read Article: Were Nitazenes Present in Most Ontario Opioid Deaths? Read the 79-of-8,719 Denominator

Why a GHB Result May Not Identify the Substance Originally Taken

Short answer: A test that reports GHB does not necessarily identify the substance a person originally took. A scientific review by Busardò and Jones explains that gamma-butyrolactone (GBL) and 1,4-butanediol can convert rapidly to GHB after ingestion. The measured GHB is a real analytical finding, but the starting compound is…

Spread the love

Read Article: Why a GHB Result May Not Identify the Substance Originally Taken

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us